Pictet Asset Management (UK)’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-291,120
| Closed | -$3.7M | – | 920 |
|
|
2018
Q1 | $3.7M | Sell |
291,120
-1,674,351
| -85% | -$21.3M | 0.01% | 714 |
|
|
2017
Q4 | $22.5M | Buy |
1,965,471
+314,931
| +19% | +$3.61M | 0.06% | 366 |
|
|
2017
Q3 | $20.2M | Buy |
1,650,540
+1,014,290
| +159% | +$12.4M | 0.06% | 362 |
|
|
2017
Q2 | $9.8M | Buy |
636,250
+24,544
| +4% | +$378K | 0.03% | 481 |
|
|
2017
Q1 | $12.7M | Buy |
611,706
+251,249
| +70% | +$5.23M | 0.04% | 435 |
|
|
2016
Q4 | $7.5M | Buy |
360,457
+167,821
| +87% | +$3.49M | 0.03% | 504 |
|
|
2016
Q3 | $6.31M | Sell |
192,636
-240,418
| -56% | -$7.88M | 0.02% | 533 |
|
|
2016
Q2 | $13M | Buy |
433,054
+353,254
| +443% | +$10.6M | 0.05% | 377 |
|
|
2016
Q1 | $1.52M | Buy |
79,800
+19,400
| +32% | +$368K | 0.01% | 724 |
|
|
2015
Q4 | $2M | Buy |
60,400
+14,000
| +30% | +$462K | 0.01% | 724 |
|
|
2015
Q3 | $1.52M | Buy |
46,400
+2,300
| +5% | +$75.3K | 0.01% | 746 |
|
|
2015
Q2 | $2.05M | Sell |
44,100
-18,600
| -30% | -$863K | 0.01% | 745 |
|
|
2015
Q1 | $1.6M | Buy |
+62,700
| New | +$1.6M | 0.01% | 769 |
|